|Bid||233.00 x 1000|
|Ask||242.22 x 800|
|Day's range||237.10 - 238.56|
|52-week range||228.62 - 287.32|
|Beta (5Y monthly)||0.51|
|PE ratio (TTM)||46.58|
|Earnings date||31 Jan 2024 - 05 Feb 2024|
|Forward dividend & yield||3.80 (1.59%)|
|Ex-dividend date||07 Dec 2023|
|1y target est||282.00|
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present the next installment of its BD Innovates series, which will highlight its Pharmaceutical Systems business on Monday, December 11, 2023, at 11:30 am Eastern Time. The BD Innovates series spotlights BD's innovation, products and pipeline in support of its BD 2025 Strategy.
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
The U.S. Food and Drug Administration (FDA) said on Friday that Becton Dickinson is recalling its Alaris infusion pumps due to compatibility issues with Cardinal Health's Monoject syringes. The health regulator said Alaris pumps are validated for use with Monoject syringes.